Why it matters:
As Iran aims to reduce its reliance on imports and strengthen its healthcare infrastructure, the introduction of new drugs and vaccines, such as HPV and pentavalent vaccines, marks a strategic shift towards pharmaceutical independence and innovation.
What he’s saying:
“This production's start is just the first step in addressing the country’s needs,” Zafarghandi stated. “With expert support and sufficient backing, we aim to fully meet internal demand, particularly for vital areas like cancer vaccines.”
Key points:
- 23 new vital medicines unveiled
- Expansion of vaccine manufacturing, including HPV and pentavalent
- Implementation of a national strategy to reduce import dependency and enhance self-reliance.
- Development of Barkat Pharmaceutical Town as a key pharmaceutical hub.
- Plans are in progress for the large-scale production of cancer medications.
Go deeper:
During a visit to the new vaccine production lines, Zafarghandi emphasized that Iran is closing the gap with global standards in drug and vaccine production. “This transformation not only conserves foreign currency,” he noted, “but also lays the groundwork for expanding pharmaceutical expertise and innovation across the country.”
محمود مجدی
